Dr. McBride on the Emergence of Biosimilars in Oncology

Ali McBride, PharmD, MS, BCOP, FASHP, FAzPA, clinical coordinator, Hematology/Oncology, The University of Arizona Cancer Center, clinical assistant professor, The University of Arizona College of Pharmacy, discusses factors that need to be taken into consideration as biosimilars emerge in oncology.

Website:
Twitter:
Facebook:
LinkedIn:

cancer,oncology,biosimilar,